Status:
NOT_YET_RECRUITING
Radial Artery Versus No-touch Saphenous Vein
Lead Sponsor:
China National Center for Cardiovascular Diseases
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study evaluates the short-term and long-term patency of the radial artery and the No-touch vein in patients undergoing isolated on-pump/off-pump coronary artery bypass graft (CABG) surgery. A tot...
Detailed Description
CABG is still the treatment of choice for ischemic heart disease. However, restenosis or occlusion may occur to graft vessels, leading to postoperative myocardial ischemia and subsequent clinical even...
Eligibility Criteria
Inclusion
- Age more than 18 years old
- First time undergo isolated CABG surgery
- Severe three-vessel disease (Left anterior decending artery, Left circumflex artery, Right coronoary artery lesion with more than 75% stenosis)
Exclusion
- Urgent or Redo CABG surgery
- Concomitant cardiac or vascular procedures (i.e. valve repair or replacement, Morrow procedure)
- A positive Allen test, radial artery plaque on ultrasound or a history of vasculitis or Raynaud's syndrome
- Varicose great saphenous vein or venous tortuosity and judged as can not be used in operation by surgeons
- Known allergy to radiographic contrast media
- Planed endarterectomy of coronary artery before surgery
- Malignant tumor or other severe systemic diseases
- Combined with other irreversible organ failures
- Contraindications for dual antiplatelet therapy, such as active gastroduodenal ulcer
- Participant of other ongoing clinical trials in 30 days.
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2030
Estimated Enrollment :
774 Patients enrolled
Trial Details
Trial ID
NCT06014047
Start Date
November 1 2023
End Date
October 30 2030
Last Update
October 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fuwai Hospital Chinese Academay of Medical Science and National Center for Cardiovascular Diseases
Beijing, Beijing Municipality, China, 100037